Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases	Clear-cell metastatic renal cell carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, metastatic malignant neoplasm, neoplasm, renal cell carcinoma, urinary system disorder	Recruiting	Phase 2	2026-07-27		NCT07043608

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Exelixis	77
Kelly Fitzgerald, MD	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, San Francisco	San Francisco	United States	294